Medical progress - Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

被引：791
作者：
Grinspoon, S
Carr, A
机构：
[1] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] St Vincents Hosp, HIV Immunol & Infect Dis Clin Serv Unit, Sydney, NSW 2010, Australia
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 352卷 / 01期
关键词：
D O I：
10.1056/NEJMra041811
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：48 / 62
页数：15
相关论文
共 100 条
[1]   Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes [J].
Arioglu, E ;
Duncan-Morin, J ;
Sebring, N ;
Rother, KI ;
Gottlieb, N ;
Lieberman, J ;
Herion, D ;
Kleiner, DE ;
Reynolds, J ;
Premkumar, A ;
Sumner, AE ;
Hoofnagle, J ;
Reitman, ML ;
Taylor, SI .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (04) :263-274
[2]   Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults [J].
Badiou, S ;
De Boever, CM ;
Dupuy, AM ;
Baillat, V ;
Cristol, JP ;
Reynes, J .
ATHEROSCLEROSIS, 2004, 172 (02) :273-279
[3]   Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy [J].
Barreiro, P ;
Soriano, V ;
Blanco, F ;
Casimiro, C ;
de la Cruz, JJ ;
González-Lahoz, J .
AIDS, 2000, 14 (07) :807-812
[4]   Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia [J].
Barrios, A ;
Blanco, F ;
García-Benayas, T ;
Gómez-Viera, JM ;
de la Cruz, JJ ;
Soriano, V ;
González-Lahoz, J .
AIDS, 2002, 16 (15) :2079-2081
[5]   Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance [J].
Bastard, JP ;
Caron, M ;
Vidal, H ;
Jan, V ;
Auclair, M ;
Vigouroux, C ;
Luboinski, J ;
Laville, M ;
Malachi, M ;
Girard, PM ;
Rozenbaum, W ;
Levan, P ;
Capeau, J .
LANCET, 2002, 359 (9311) :1026-1031
[6]   Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy [J].
Behrens, GMN ;
Boerner, AR ;
Weber, K ;
van den Hoff, J ;
Ockenga, J ;
Brabant, G ;
Schmidt, RE .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (09) :1319-1327
[7]   Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitors [J].
Ben-Romano, R ;
Rudich, A ;
Torök, D ;
Vanounou, S ;
Riesenberg, K ;
Schiaeffer, F ;
Klip, A ;
Bashan, N .
AIDS, 2003, 17 (01) :23-32
[8]   Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs - The Swiss HIV cohort study [J].
Bernasconi, E ;
Boubaker, K ;
Junghans, C ;
Flepp, M ;
Furrer, HJ ;
Haensel, A ;
Hirschel, B ;
Boggian, K ;
Chave, JP ;
Opravil, M ;
Weber, R ;
Rickenbach, M ;
Telenti, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (01) :50-55
[9]   Apoprotein C-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors:: Association with the development of lipodystrophy [J].
Bonnet, E ;
Ruidavets, JB ;
Tuech, J ;
Ferrières, J ;
Collet, X ;
Fauvel, J ;
Massip, P ;
Perret, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :296-302
[10]   Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection [J].
Bozzette, SA ;
Ake, CF ;
Tam, HK ;
Chang, SW ;
Louis, TA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08) :702-710
12345678910